AR051237A1 - Sistema de capsula blanda sin gelatina - Google Patents

Sistema de capsula blanda sin gelatina

Info

Publication number
AR051237A1
AR051237A1 ARP050104668A ARP050104668A AR051237A1 AR 051237 A1 AR051237 A1 AR 051237A1 AR P050104668 A ARP050104668 A AR P050104668A AR P050104668 A ARP050104668 A AR P050104668A AR 051237 A1 AR051237 A1 AR 051237A1
Authority
AR
Argentina
Prior art keywords
fillers
conductor
active ingredients
gelatine
encapsulation
Prior art date
Application number
ARP050104668A
Other languages
English (en)
Spanish (es)
Inventor
Rickey S Shelley
Norman Stroud
Elizabeth Youngblood
Keith Tanner
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Publication of AR051237A1 publication Critical patent/AR051237A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ARP050104668A 2004-11-08 2005-11-08 Sistema de capsula blanda sin gelatina AR051237A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/984,205 US8231896B2 (en) 2004-11-08 2004-11-08 Non-gelatin soft capsule system

Publications (1)

Publication Number Publication Date
AR051237A1 true AR051237A1 (es) 2006-12-27

Family

ID=36316590

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104668A AR051237A1 (es) 2004-11-08 2005-11-08 Sistema de capsula blanda sin gelatina

Country Status (19)

Country Link
US (2) US8231896B2 (de)
EP (2) EP1809261B1 (de)
JP (1) JP5192816B2 (de)
AR (1) AR051237A1 (de)
AT (1) ATE536866T1 (de)
AU (1) AU2005305232B2 (de)
BR (1) BRPI0517674B8 (de)
CA (1) CA2585721C (de)
CY (1) CY1112518T1 (de)
DK (1) DK1809261T3 (de)
ES (2) ES2379970T3 (de)
MX (1) MX2007005403A (de)
PE (1) PE20061136A1 (de)
PL (1) PL1809261T3 (de)
PT (1) PT1809261E (de)
SI (1) SI1809261T1 (de)
TW (1) TWI405592B (de)
UY (1) UY29200A1 (de)
WO (1) WO2006052452A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US20070053868A1 (en) * 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
DK3095447T3 (da) 2006-02-03 2022-01-31 Opko Renal Llc Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3
CN104825397A (zh) * 2006-04-03 2015-08-12 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
DK2679228T3 (en) 2006-06-21 2018-06-06 Opko Ireland Global Holdings Ltd Therapy with a vitamin D refill and a vitamin D hormone replacement
JP5021263B2 (ja) * 2006-10-02 2012-09-05 中日本カプセル 株式会社 皮膜用組成物
EP3225243B1 (de) 2007-04-25 2025-09-03 Opko Renal, LLC Verfahren zur sicheren und effektiven behandlung und vorbeugung von sekundärem hyperparathyroidismus für chronische nierenerkrankung
PL3542792T3 (pl) 2007-04-25 2023-11-20 Eirgen Pharma Ltd. 25-hydroksywitamina d o kontrolowanym uwalnianiu
ES2403107T3 (es) 2007-04-25 2013-05-14 Cytochroma Inc. Método de tratamiento de insuficiencia y deficiencia de vitamina D
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
CA2610819A1 (en) * 2007-12-12 2008-12-02 Multi Formulations Ltd. Particles in a capsule
GB0801643D0 (en) * 2008-01-29 2008-03-05 Probio Nutraceuticals As Product
US8962239B2 (en) 2008-04-02 2015-02-24 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
JP5696149B2 (ja) 2009-09-10 2015-04-08 エフ エム シー コーポレーションFmc Corporation シームレスなアルギン酸塩カプセル
SMT202000167T1 (it) 2010-03-29 2020-05-08 Opko Ireland Global Holdings Ltd Metodi e composizioni per la riduzione dei livelli paratiroidei
CA2807314C (en) * 2010-08-04 2017-06-20 R.P. Scherer Technologies, Llc Film-forming composition for soft capsules
KR101411364B1 (ko) * 2012-03-16 2014-06-30 주식회사 서흥 전분을 주기재로 사용한 연질 캡슐 피막 조성물
KR101178842B1 (ko) * 2011-04-20 2012-09-03 주식회사 서흥캅셀 붕해도 및 피막 경도를 개선한 비동물성 연질 캡슐 피막 조성물
KR101294614B1 (ko) 2012-03-16 2013-08-08 주식회사 서흥캅셀 타피오카 변성전분을 주기재로 사용한 연질 캡슐 피막 조성물
JP5597770B2 (ja) * 2011-04-20 2014-10-01 サフン カプセル カンパニー, リミテッド 崩解度及び被膜硬度を改善した非動物性軟質カプセル被膜組成物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
US9980916B2 (en) 2013-03-15 2018-05-29 Patheon Softgels, Inc. Non-gelatin enteric soft capsules
KR101445334B1 (ko) * 2013-06-05 2014-10-01 코스맥스바이오 주식회사 화학적 금속염을 포함하지 않는 식물성 연질캡슐조성물
JP5769760B2 (ja) * 2013-06-25 2015-08-26 アール.ピー. シェーラー テクノロジーズ エルエルシー ソフトカプセル用シェル形成組成物及びソフトカプセル
US20150010622A1 (en) * 2013-07-03 2015-01-08 R.P. Scherer Technologies, Llc Capsule formulation comprising fexofenadine
WO2015059864A1 (ja) * 2013-10-25 2015-04-30 コニカミノルタ株式会社 粒子状肥料およびその製造方法
CN103520133B (zh) * 2013-10-26 2015-02-04 中山市凯博思淀粉材料科技有限公司 一种淀粉基软胶囊的制备方法
CN103495176B (zh) * 2013-10-26 2015-01-28 中山市凯博思淀粉材料科技有限公司 一种共混挤出法制备淀粉基软胶囊的方法
CN103550065B (zh) * 2013-10-26 2015-01-28 中山市凯博思淀粉材料科技有限公司 一种复合挤出法生产淀粉基软胶囊的方法
CN103893771B (zh) * 2014-04-21 2015-08-26 湖南尔康制药股份有限公司 一种用于生产淀粉材料软胶囊的成膜组合物及其制备方法
CA2910865C (en) 2014-07-15 2016-11-29 Isa Odidi Compositions and methods for reducing overdose
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
CN104337793A (zh) * 2014-10-16 2015-02-11 浙江春宝胶囊有限公司 一种非明胶软胶囊壳的配方
AU2016361585A1 (en) 2015-11-23 2018-07-12 Undoo, LLC Composition of olivetol and method of use reduce or inhibit the effects of tetrahydrocannabinol in the human body
JP6926453B2 (ja) * 2015-12-03 2021-08-25 大正製薬株式会社 カプセル組成物
SG11201808227YA (en) 2016-03-28 2018-10-30 Opko Ireland Global Holdings Limited Methods of vitamin d treatment
CA3024584A1 (en) * 2016-05-25 2017-11-30 TSI Group Ltd. Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules
US11629118B2 (en) 2017-03-03 2023-04-18 Inspirna, Inc. Formulations with improved stability
US10711119B2 (en) 2018-01-10 2020-07-14 Cp Kelco Aps Carrageenan-based compositions for films and capsules
EP4003310A4 (de) * 2019-07-23 2023-08-02 R.P. Scherer Technologies, LLC Weichkapselformulierungen sowie verfahren zu ihrer herstellung und ihre verwendung
US20240189241A1 (en) * 2021-04-01 2024-06-13 R.P. Scherer Technologies, Llc Phospholipids as anion chelating agents in pharmaceutical formulations
AR126384A1 (es) * 2021-07-06 2023-10-11 Scherer Technologies Llc R P Cápsula blanda
AU2021107198A4 (en) * 2021-08-24 2021-12-09 Blackmores Ltd A softgel capsule composition, and a process for producing a softgel capsule therefrom
EP4176724A1 (de) 2021-11-09 2023-05-10 Universität Hohenheim Verwendung eines oleogels als eine schicht oder beschichtung
AU2023321676A1 (en) * 2022-08-12 2025-03-20 R.P. Scherer Technologies, Llc Fast dissolving softgel capsules
WO2025042689A1 (en) * 2023-08-18 2025-02-27 R.P. Scherer Technologies, Llc Softgel capsule including a non-steroidal anti-inflammatory drug and acetaminophen
WO2025064293A1 (en) * 2023-09-18 2025-03-27 R.P. Scherer Technologies, Llc Fast dissolving softgel capsules including ibuprofen

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2118040A (en) 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
GB8305693D0 (en) 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
DE3307353C2 (de) 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung
US5071643A (en) 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
JPS63164858A (ja) * 1986-12-27 1988-07-08 Unie Koroido Kk 軟カプセルの外皮
JPH0525037A (ja) 1991-07-01 1993-02-02 Upjohn Co:The 経口投与酵素感受性腸溶製剤
GB9226238D0 (en) 1992-12-16 1993-02-10 Scherer Ltd R P Encapsulation apparatus and process
US5376688A (en) 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5505961A (en) 1993-08-05 1996-04-09 R. P. Scherer Corporation Gelatin capsules containing a highly concentrated acetaminophen solution
GB9705770D0 (en) 1997-03-20 1997-05-07 Scherer Corp R P Gelatin encapsulation techniques
US20030104048A1 (en) 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
US6884060B2 (en) 2001-11-02 2005-04-26 R.P. Scherer Technologies, Inc. Apparatus for manufacturing encapsulated products
US7887838B2 (en) 2002-01-18 2011-02-15 Banner Pharmacaps, Inc. Non-gelatin film and method and apparatus for producing same
RU2359698C2 (ru) * 2002-09-13 2009-06-27 Сайдекс, Инк. Капсулы, содержащие водные наполняющие композиции, стабилизированные производным циклодекстрина
JP2004250369A (ja) * 2003-02-19 2004-09-09 Fuji Capsule Kk 軟カプセル剤皮膜組成物
US20050137262A1 (en) 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses

Also Published As

Publication number Publication date
CA2585721A1 (en) 2006-05-18
US20120269889A1 (en) 2012-10-25
SI1809261T1 (sl) 2013-09-30
BRPI0517674B1 (pt) 2019-04-02
EP1809261A4 (de) 2008-09-10
AU2005305232A1 (en) 2006-05-18
ES2379970T3 (es) 2012-05-07
US8377470B2 (en) 2013-02-19
MX2007005403A (es) 2007-05-16
JP2008519075A (ja) 2008-06-05
EP2289496B1 (de) 2016-08-17
BRPI0517674A (pt) 2008-10-14
CA2585721C (en) 2014-07-15
BRPI0517674B8 (pt) 2021-05-25
EP2289496A2 (de) 2011-03-02
ES2603225T3 (es) 2017-02-24
HK1108363A1 (en) 2008-05-09
PL1809261T3 (pl) 2012-06-29
EP1809261A1 (de) 2007-07-25
TWI405592B (zh) 2013-08-21
PT1809261E (pt) 2012-04-11
TW200630122A (en) 2006-09-01
ATE536866T1 (de) 2011-12-15
UY29200A1 (es) 2006-06-30
AU2005305232B2 (en) 2010-03-25
US8231896B2 (en) 2012-07-31
US20060099246A1 (en) 2006-05-11
WO2006052452A1 (en) 2006-05-18
DK1809261T3 (da) 2012-04-02
PE20061136A1 (es) 2006-10-27
JP5192816B2 (ja) 2013-05-08
EP1809261B1 (de) 2011-12-14
CY1112518T1 (el) 2015-12-09
EP2289496A3 (de) 2011-03-09

Similar Documents

Publication Publication Date Title
AR051237A1 (es) Sistema de capsula blanda sin gelatina
AR024966A1 (es) Formulacion farmaceutica
ES2166781T3 (es) Preparados farmaceuticos para el tratamiento selectivo de la enfermedad de crohn y colitis ulcerosa.
DE60009472D1 (de) Schnell dispergierende darreichungsformen, die fischgelatine enthalten
PE20000512A1 (es) Capsula doble para la administracion de principios activos en terapias multiples
AR090677A2 (es) Preparacion farmaceutica que contiene oxicodona y naloxona
CO6511280A2 (es) Pastillas de gelatina blanda con nicotina
AR049137A1 (es) Formulacion de irinotecan en vesicula cerrada, para el tratamiento del cancer
CO6321129A2 (es) Inhibidor de la cristalizacion y su uso en capsulas de gelatina
DK1680096T3 (da) Hidtil ukendt formulering til retinoidholdige blöde gelatinekapsler
MX418137B (es) Preparaciones de capsulas de gelatina blanda de vitaminas y minerales que comprenden vitamina c en forma de una sal de ascorbato
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
ES2529568T3 (es) Uso de cuerpos moldeados para aplicación externa
DE60331920D1 (de) Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren
Bondarenko et al. Calcium ion supplementation increases brook trout Salvelinus fontinalis spermatozoa activation at the end of the spawning season
TH84332A (th) ระบบแคปซูลนิ่มที่ไม่ใช่เจลาติน
CO2023009202A2 (es) Formulaciones de gel líquido concentradas que contienen sales de naproxeno
TH84332B (th) ระบบแคปซูลนิ่มที่ไม่ใช่เจลาติน
Orlando 1. Iii JA, Minning T, Ludolf F, Nuccio A, Weatherly DB, Alvarez-Manilla G, Tarleton R
Arroyo Sibaja Psychosocial characterization of medication consumption in Costa Rica: state of the art
GT200000187A (es) Un estuche de combinacion usado en el tratamiento del paludismo.
de Paula et al. Conflict in relationships interpessoais arising from the factors that dificultam communication nurses/at customer care
SANITARIA Analysis of the determining factors of therapeutic adherence in hypertensive patients
MX2021010959A (es) Estabilidad mejorada de ingredientes farmaceuticos activos (api) en capsulas blandas.
ES2119682B1 (es) Una composicion farmaceutica que contiene delapril y manidipino para el tratamiento de enfermedades cardiovasculares y renales.

Legal Events

Date Code Title Description
FC Refusal